知镜 Cognispect · 医学文献与研究工作台

Reproductive health guidance for the cystic fibrosis community: a Cystic Fibrosis Foundation Position Paper.

Jain R, Taylor JL, Kazmerski TM, Lonabaugh K, Trimble A, Velez Leitner D, Foil K, Hong G, Johns WB, Kolarova T, Meier E, Perry A, Singh KE, Stahl C, Szentpetery S, Weiss MS, West NE, Wilson A, Wright B, Brown AW, Hempstead SE, Lomas P, Middleton PG, Shteinberg M, Felton I, Roe AH.
The Lancet. Respiratory medicine · 2026-07-13 · PMID 42442376

文献摘要

The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current knowledge and best practices in reproductive health care for individuals with cystic fibrosis. Working groups reviewed the literature and provided relevant guidance on reproductive health services, fertility, contraception, preconception and pregnancy, and cystic fibrosis transmembrane conductance regulator (CFTR) modulator exposure in utero and during lactation. Findings included: (1) reproductive health-care provision should be standardised, and education should begin at cystic fibrosis diagnosis and revisited annually; (2) contraception is safe overall, but underutilised in those with cystic fibrosis compared with the general population; (3) fertility might be improving with CFTR modulators for females with cystic fibrosis, but not for males with cystic fibrosis-assisted reproductive technologies are still required for males to achieve biological parenthood; (4) pregnancy requires close monitoring and unique screening for diabetes; and (5) CFTR modulator exposure in utero has implications for infant monitoring and cystic fibrosis screening results in newborns.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。